메뉴 건너뛰기




Volumn 7, Issue 6, 2014, Pages 2180-2184

Circulating free mitochondrial DNA concentration and its association with erlotinib treatment in patients with adenocarcinoma of the lung

Author keywords

Epidermal growth factor receptor; Lung cancer; Mitochondria; Tyrosine kinase inhibitor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; MITOCHONDRIAL DNA;

EID: 84898874460     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2006     Document Type: Article
Times cited : (13)

References (26)
  • 1
    • 77649322365 scopus 로고    scopus 로고
    • Second-line therapy for elderly patients with non-small cell lung cancer who failed previous chemotherapy is as effective as for younger patients
    • Wu CH, Fan WC, Chen YM, Chou KT, Shih JF, Tsai CM, et al: Second-line therapy for elderly patients with non-small cell lung cancer who failed previous chemotherapy is as effective as for younger patients. J Thorac Oncol 5: 376-379, 2010.
    • (2010) J Thorac Oncol , vol.5 , pp. 376-379
    • Wu, C.H.1    Fan, W.C.2    Chen, Y.M.3    Chou, K.T.4    Shih, J.F.5    Tsai, C.M.6
  • 3
    • 33749128507 scopus 로고    scopus 로고
    • Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool
    • Pathak AK, Bhutani M, Kumar S, Mohan A and Guleria R: Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool. Clin Chem 52: 1833-1842, 2006.
    • (2006) Clin Chem , vol.52 , pp. 1833-1842
    • Pathak, A.K.1    Bhutani, M.2    Kumar, S.3    Mohan, A.4    Guleria, R.5
  • 4
    • 58549084394 scopus 로고    scopus 로고
    • Quantification of circulating cell-free DNA in the plasma of cancer patients during radiation therapy
    • Cheng C, Omura-Minamisawa M, Kang Y, Hara T, Koike I and Inoue T: Quantification of circulating cell-free DNA in the plasma of cancer patients during radiation therapy. Cancer Sci 100: 303-309, 2009.
    • (2009) Cancer Sci , vol.100 , pp. 303-309
    • Cheng, C.1    Omura-Minamisawa, M.2    Kang, Y.3    Hara, T.4    Koike, I.5    Inoue, T.6
  • 5
    • 0030792850 scopus 로고    scopus 로고
    • Mitochondrial proliferation and paradoxical membrane depolarization during terminal differentiation and apoptosis in a human colon carcinoma cell line
    • Mancini M, Anderson BO, Caldwell E, Sedghinasab M, Paty PB and Hockenbery DM: Mitochondrial proliferation and paradoxical membrane depolarization during terminal differentiation and apoptosis in a human colon carcinoma cell line. J Cell Biol 138: 449-469, 1997.
    • (1997) J Cell Biol , vol.138 , pp. 449-469
    • Mancini, M.1    Anderson, B.O.2    Caldwell, E.3    Sedghinasab, M.4    Paty, P.B.5    Hockenbery, D.M.6
  • 6
    • 48749131866 scopus 로고    scopus 로고
    • Mitochondrial DNA in serum of patients with prostate cancer: A predictor of biochemical recurrence after prostatectomy
    • Ellinger J, Müller SC, Wernert N, von Ruecker A and Bastian PJ: Mitochondrial DNA in serum of patients with prostate cancer: a predictor of biochemical recurrence after prostatectomy. BJU Int 102: 628-632, 2008.
    • (2008) BJU Int , vol.102 , pp. 628-632
    • Ellinger, J.1    Müller, S.C.2    Wernert, N.3    von Ruecker, A.4    Bastian, P.J.5
  • 7
    • 77954143056 scopus 로고    scopus 로고
    • Value of quantitative analysis of circulating cell free DNA as a screening tool for lung cancer: A meta-analysis
    • Zhang R, Shao F, Wu X and Ying K: Value of quantitative analysis of circulating cell free DNA as a screening tool for lung cancer: A meta-analysis. Lung Cancer 69: 225-231, 2010.
    • (2010) Lung Cancer , vol.69 , pp. 225-231
    • Zhang, R.1    Shao, F.2    Wu, X.3    Ying, K.4
  • 8
    • 57849117384 scopus 로고    scopus 로고
    • New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
    • Eisenhauer EA, Therasse P, Bogaerts J, et al: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45: 228-247, 2009.
    • (2009) Eur J Cancer , vol.45 , pp. 228-247
    • Eisenhauer, E.A.1    Therasse, P.2    Bogaerts, J.3
  • 10
    • 14744275382 scopus 로고    scopus 로고
    • Serum tissue inhibitors of metalloproteinase-1 and -2 in patients with non-small cell lung cancer
    • Suemitsu R, Yoshino I, Tomiyasu M, Fukuyama S, Okamoto T and Maehara Y: Serum tissue inhibitors of metalloproteinase-1 and -2 in patients with non-small cell lung cancer. Surg Today 34: 896-901, 2004.
    • (2004) Surg Today , vol.34 , pp. 896-901
    • Suemitsu, R.1    Yoshino, I.2    Tomiyasu, M.3    Fukuyama, S.4    Okamoto, T.5    Maehara, Y.6
  • 11
    • 0036841417 scopus 로고    scopus 로고
    • Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients
    • Kulpa J, Wójcik E, Reinfuss M and Kolodziejski L: Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients. Clin Chem 48: 1931-1937, 2002.
    • (2002) Clin Chem , vol.48 , pp. 1931-1937
    • Kulpa, J.1    Wójcik, E.2    Reinfuss, M.3    Kolodziejski, L.4
  • 12
    • 0035875037 scopus 로고    scopus 로고
    • Analysis of circulating DNA in plasma at diagnosis and during follow-up of lung cancer patients
    • Sozzi G, Conte D, Mariani L, et al: Analysis of circulating DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res 61: 4675-4678, 2001.
    • (2001) Cancer Res , vol.61 , pp. 4675-4678
    • Sozzi, G.1    Conte, D.2    Mariani, L.3
  • 13
    • 0642311916 scopus 로고    scopus 로고
    • Quantification of free circulating DNA as a diagnostic marker in lung cancer
    • Sozzi G, Conte D, Leon M, et al: Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 21: 3902-3908, 2003.
    • (2003) J Clin Oncol , vol.21 , pp. 3902-3908
    • Sozzi, G.1    Conte, D.2    Leon, M.3
  • 14
    • 1942469436 scopus 로고    scopus 로고
    • Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR
    • Gai S, Fidler C, Lo YM, et al: Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR. Br J Cancer 90: 1211-1215, 2004.
    • (2004) Br J Cancer , vol.90 , pp. 1211-1215
    • Gai, S.1    Fidler, C.2    Lo, Y.M.3
  • 15
    • 33845805706 scopus 로고    scopus 로고
    • Free DNA and carcinoembryonic antigen serum levels: An important combination for diagnosis of colorectal cancer
    • Flamini E, Mercatali L, Nanni O, et al: Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer. Clin Cancer Res 12: 6985-6988, 2006.
    • (2006) Clin Cancer Res , vol.12 , pp. 6985-6988
    • Flamini, E.1    Mercatali, L.2    Nanni, O.3
  • 17
    • 34248569300 scopus 로고    scopus 로고
    • Circulating free DNA in plasma or serum as biomarker of carcinogenesis: Practical aspects and biological significance
    • Gormally E, Caboux E, Vineis P and Hainaut P: Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat Res 635: 105-117, 2007.
    • (2007) Mutat Res , vol.635 , pp. 105-117
    • Gormally, E.1    Caboux, E.2    Vineis, P.3    Hainaut, P.4
  • 20
    • 33749128507 scopus 로고    scopus 로고
    • Circulating free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool
    • Pathak AK, Bhutani M, Kumar S, Mohan A and Guleria R: Circulating free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool. Clin Chem 52: 1833-1842, 2006.
    • (2006) Clin Chem , vol.52 , pp. 1833-1842
    • Pathak, A.K.1    Bhutani, M.2    Kumar, S.3    Mohan, A.4    Guleria, R.5
  • 21
    • 84857502654 scopus 로고    scopus 로고
    • Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation positive non-small-cell lung cancer (EURTAC): A multicentre, open-label, randomised phase 3 trial
    • Rosell R, Carcereny E, Gervais R, et al: Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol 13: 239-246, 2012.
    • (2012) Lancet Oncol , vol.13 , pp. 239-246
    • Rosell, R.1    Carcereny, E.2    Gervais, R.3
  • 22
    • 84859813987 scopus 로고    scopus 로고
    • Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: Association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib
    • Punnoose EA, Atwal S, Liu W, et al: Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib. Clin Cancer Res 18: 2391-2401, 2012.
    • (2012) Clin Cancer Res , vol.18 , pp. 2391-2401
    • Punnoose, E.A.1    Atwal, S.2    Liu, W.3
  • 25
    • 0017360626 scopus 로고
    • Free DNA in the serum of cancer patients and the effect of therapy
    • Leon SA, Shapiro B, Sklaroff DM and Yaros MJ: Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37: 646-650, 1977.
    • (1977) Cancer Res , vol.37 , pp. 646-650
    • Leon, S.A.1    Shapiro, B.2    Sklaroff, D.M.3    Yaros, M.J.4
  • 26
    • 77956487870 scopus 로고    scopus 로고
    • Plasma DNA level in predicting therapeutic efficacy in advanced nonsmall cell lung cancer
    • Kumar S, Guleria R, Singh V, et al: Plasma DNA level in predicting therapeutic efficacy in advanced nonsmall cell lung cancer. Eur Respir J 36: 885-892, 2010.
    • (2010) Eur Respir J , vol.36 , pp. 885-892
    • Kumar, S.1    Guleria, R.2    Singh, V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.